Ancestry and genetic associations with bronchopulmonary dysplasia in preterm infants

Keyphrases

• Admixture Mapping 20%
• African American 20%
• African Ancestry 20%
• Bone Morphogenetic Protein 20%
• Bronchopulmonary Dysplasia 100%
• CCL18 20%
• Chromosome Banding 20%
• Differential Response 20%
• Disease Analysis 20%
• Drug Metabolism 20%
• Ethnic Differences 20%
• Exhaled Nitric Oxide 40%
• Fibrosis 20%
• Genetic Ancestry 20%
• Genetic Association 100%
• Genetic Components 20%
• Genetic Variation 20%
• Genome-wide Association Study 20%
• High Risk 20%
• High-risk Infants 20%
• Hispanic Whites 20%
• Immune Response 20%
• Immune-inflammatory Response 20%
• Improved Survival 20%
• Inflammatory Process 20%
• Interstitial Lung Disease 20%
• Long-term Sequelae 20%
• Lung 40%
• Lung Development 20%
• Mechanical Ventilation 20%
• Metabolism Response 20%
• Midtrimester 20%
• NBL1 20%
• Nitric Oxide 20%
• Nitric Oxide Metabolites 20%
• Non-Hispanic White 20%
• Odds Ratio 40%
• Outcome Association 20%
• Path Analysis 20%
• Premature Infant 40%
• Preterm Infants 100%
• Protective Allele 20%
• Race-ethnicity 40%
• Racial Differentials 20%
• Respiratory Outcomes 20%
• Response to Infection 20%
• Severe Lung Disease 20%
• Surfactant 20%
• Variant Gene 20%
• White Race 20%

Medicine and Dentistry

• Allele 20%
• Artificial Respiration 20%
• Bone Morphogenetic Protein 20%
• Chromosome Band 20%
• Cytokine 20%
• Drug Metabolism 20%
• Ethnic Difference 20%
• Fibrosis 20%
• Genetic Association 100%
• Genetic Variation 20%
• Genetics 40%
• Genome Wide Association Study 20%
• High Risk Infant 20%
• Immune Response 20%
• Infection 20%
• Interstitial Lung Disease 20%
• Intron 20%
• Lung 40%
• Lung Development 20%
• Lung Dysplasia 100%
• Metabolite 20%
• Nitric Oxide 80%
• Odds Ratio 40%
• Prematurity 40%
• Sequela 20%
• Serositis 20%
• Silo-Filler's Disease 20%
• Surfactant 20%